Accord Healthcare Polska Sp. z o.o. Importer's Warehouse (Responsible for batch release)

The drug is used to treat patients with metastatic colorectal cancer. It may be used as monotherapy or in combination with other drugs (e.g., 5-fluorouracil, folinic acid, bevacizumab, cetuximab, or capecitabine).

Dosage form: concentrate for infusion solution

ATC: L01CE02

The drug is used for the treatment of adult patients with breast cancer (metastatic or early) and metastatic gastric cancer, if the tumors show overexpression or amplification of the HER2 gene.

Dosage form: powder for concentrate for infusion solution

ATC: L01FD01